speb/financial-data huggingface dataset:
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4029000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 2286000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2286000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 12891000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 12891000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -504000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 280000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 280000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 2006000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 2006000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 30000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -1461000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Change In Payable: 2211000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -199000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 581000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -1602000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Common Stock: 4029000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 4029000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -504000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 48390000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 48390000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 4000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 10457000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 10457000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 9186000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2331000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Current Assets: 21428000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 21428000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 505000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 505000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Current Debt: 94000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 94000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 599000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 599000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 15523000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 15523000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 1144000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 1144000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 931000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Depreciation: 4423000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 4529000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4528000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1115000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 4422000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1115000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Derivative Product Liabilities: 488000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 488000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 402997275.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.67
SYNGENE.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 3167000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1479000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — EBIT: 4557000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — EBIT: 2081000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — EBITDA: 9086000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — EBITDA: 3196000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 217000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — End Cash Position: 2286000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Financial Assets: 317000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets: 317000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 101000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 101000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -2150000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 40000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 40000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 5470000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -66000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1825000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 439000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 439000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 5208000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 5208000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 67580000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 67580000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Gross Profit: 26921000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 8034000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 69000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 69000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Interest Expense: 448000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 121000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 448000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 121000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Interest Income: 613000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 613000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -106000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 508000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Inventory: 1413000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1413000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 48484000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 48484000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -8604000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 315000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 315000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 5604000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 5604000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 4000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 1849000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 1849000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 3985000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3985000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3985000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3985000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: 0.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 180000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 180000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 43022000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 43022000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 4000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 37000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Net Income: 3167000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Net Income: 1479000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 3167000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1479000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 3167000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1479000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3167000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1479000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3167000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1479000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 3167000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 3167000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1479000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -242000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Net Interest Income: 165000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -121000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -5430000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -996000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 0.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 165000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -121000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Net PPE: 39756000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 39756000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -3440000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -996000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 47951000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 47951000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 1979000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 1979000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 1007000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1007000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 181000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 181000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 414000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 414000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 10065000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3256000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Normalized Income: 3921561450.47
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1524275510.20
SYNGENE.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 9152000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Operating Income: 5573000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Operating Income: 2130000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Operating Revenue: 36107000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 10365000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 401773431.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 401773431.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1663000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1663000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 937000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 937000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 439000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 439000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -114000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 121000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 121000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 707000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 222000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 4888000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1781000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Payable: 1712000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 1712000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Properties: 29299000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 29299000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 267000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 267000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 10605000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 10605000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Other Special Charges: 490000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Payables: 5464000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Payables: 5464000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1144000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1144000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 1700000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1700000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Pretax Income: 4109000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 1960000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 51000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -242000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -34597000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -3440000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 1286000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1286000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 9186000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2331000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 4529000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1115000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 58000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 58000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: 0.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 304000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 41486000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 41486000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 29167000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 224000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 2049000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Share Issued: 402939420.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 402939420.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Special Income Charges: -1073000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -60000000.00
SYNGENE.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 413000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 48390000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 48390000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 47951000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 47951000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -224438549.53
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -14724489.80
SYNGENE.NS income_statement (annual, 2026-03-31) — Tax Provision: 942000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 481000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.23
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
SYNGENE.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -693000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Total Assets: 70547000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 70547000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 48390000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 48390000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Total Debt: 4584000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 4584000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 48390000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 48390000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Total Expenses: 30534000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 8235000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 22157000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 22157000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 49119000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 49119000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6634000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6634000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 277000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 277000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -979000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -60000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -979000000.00
SYNGENE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -60000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 1165989.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 1165989.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Treasury Stock: 53000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 53000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Work In Process: 87000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 87000000.00
SYNGENE.NS balance_sheet (annual, 2026-03-31) — Working Capital: 5905000000.00
SYNGENE.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 5905000000.00
SYNGENE.NS income_statement (annual, 2026-03-31) — Write Off: 279000000.00
SYNT.L cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -73500000.00
SYNT.L cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -73500000.00
SYNT.L income_statement (annual, 2021-12-31) — Cost Of Revenue: 1479200000.00
SYNT.L cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 7400000.00
SYNT.L income_statement (annual, 2021-12-31) — General And Administrative Expense: 121000000.00
SYNT.L income_statement (annual, 2021-12-31) — Gross Profit: 665000000.00
SYNT.L income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
SYNT.L cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
SYNT.L income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 1479200000.00
SYNT.L income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 48600000.00
SYNT.L income_statement (annual, 2021-12-31) — Selling General And Administration: 169600000.00
SYNT.L income_statement (annual, 2022-12-31) — +Operating Expense: 290600000.00
SYNT.L income_statement (annual, 2022-12-31) — +Total Revenue: 2332300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 253700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Accounts Receivable: 201300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -538800000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 620900000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1600000.00
SYNT.L income_statement (annual, 2022-12-31) — Amortization: 44800000.00
SYNT.L cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 7900000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 196200000.00
SYNT.L income_statement (annual, 2022-12-31) — Basic Average Shares: 63441521.00
SYNT.L income_statement (annual, 2022-12-31) — Basic EPS: 0.52
SYNT.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 505300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 45300000.00
SYNT.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -90800000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 45500000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Capital Stock: 46700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 227700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 227700000.00
SYNT.L cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -99500000.00
SYNT.L cash_flow (annual, 2022-12-31) — Change In Inventory: -12300000.00
SYNT.L cash_flow (annual, 2022-12-31) — Change In Payable: -115600000.00
SYNT.L cash_flow (annual, 2022-12-31) — Change In Receivables: 147000000.00
SYNT.L cash_flow (annual, 2022-12-31) — Change In Working Capital: 19100000.00
SYNT.L cash_flow (annual, 2022-12-31) — Changes In Cash: -299800000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Common Stock: 46700000.00
SYNT.L cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -99500000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1017000000.00
SYNT.L cash_flow (annual, 2022-12-31) — Common Stock Issuance: -1500000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Construction In Progress: 3200000.00
SYNT.L income_statement (annual, 2022-12-31) — Cost Of Revenue: 1918700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Current Assets: 1164400000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 10600000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Current Debt: 18500000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 29100000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 582700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Current Provisions: 13700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 5900000.00
SYNT.L cash_flow (annual, 2022-12-31) — Depreciation: 86000000.00
SYNT.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 93900000.00
SYNT.L income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 129100000.00
SYNT.L income_statement (annual, 2022-12-31) — Depreciation Income Statement: 84300000.00
SYNT.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 63579859.00
SYNT.L income_statement (annual, 2022-12-31) — Diluted EPS: 0.52
SYNT.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -32500000.00
SYNT.L cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 1900000.00
SYNT.L income_statement (annual, 2022-12-31) — EBIT: 13200000.00
SYNT.L income_statement (annual, 2022-12-31) — EBITDA: 142300000.00
SYNT.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 3700000.00
SYNT.L cash_flow (annual, 2022-12-31) — End Cash Position: 209200000.00
SYNT.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: 414500000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Finished Goods: 223100000.00
SYNT.L cash_flow (annual, 2022-12-31) — Free Cash Flow: 43100000.00
SYNT.L cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 300000.00
SYNT.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 89100000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Goodwill: 480800000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1065300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 202900000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Gross PPE: 1292400000.00
SYNT.L income_statement (annual, 2022-12-31) — Gross Profit: 413600000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 26700000.00
SYNT.L income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 133700000.00
SYNT.L income_statement (annual, 2022-12-31) — Interest Expense: 47400000.00
SYNT.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 47400000.00
SYNT.L income_statement (annual, 2022-12-31) — Interest Income: 1600000.00
SYNT.L income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1600000.00
SYNT.L cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -39800000.00
SYNT.L cash_flow (annual, 2022-12-31) — Interest Received Cfo: 1600000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Inventory: 407900000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Invested Capital: 2269600000.00
SYNT.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -848200000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 8100000.00
SYNT.L cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: -1500000.00
SYNT.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 733200000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Land And Improvements: 213100000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 34900000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Long Term Debt: 1234100000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1269000000.00
SYNT.L cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 733200000.00
SYNT.L cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -207600000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 8100000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Long Term Provisions: 40300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1030800000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Minority Interest: 14000000.00
SYNT.L income_statement (annual, 2022-12-31) — Minority Interests: 500000.00
SYNT.L cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -759300000.00
SYNT.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -1500000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Net Debt: 1024900000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Income: -32500000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -32500000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -18900000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -14100000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -32500000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -18400000.00
SYNT.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -26500000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -33000000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Interest Income: -45800000.00
SYNT.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 525600000.00
SYNT.L cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 525600000.00
SYNT.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -45800000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Net PPE: 753600000.00
SYNT.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -90800000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -48300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 400000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 50300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 44900000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 79300000.00
SYNT.L income_statement (annual, 2022-12-31) — Normalized EBITDA: 255400000.00
SYNT.L income_statement (annual, 2022-12-31) — Normalized Income: 69478700.00
SYNT.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: 133900000.00
SYNT.L income_statement (annual, 2022-12-31) — Operating Income: 123000000.00
SYNT.L income_statement (annual, 2022-12-31) — Operating Revenue: 2332300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 63434954.00
SYNT.L balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 584500000.00
SYNT.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: 197700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Other Payable: 110300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Other Receivables: 62700000.00
SYNT.L income_statement (annual, 2022-12-31) — Other Special Charges: -21200000.00
SYNT.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
SYNT.L balance_sheet (annual, 2022-12-31) — Payables: 397600000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Prepaid Assets: 7600000.00
SYNT.L income_statement (annual, 2022-12-31) — Pretax Income: -34200000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Properties: 0.00
SYNT.L cash_flow (annual, 2022-12-31) — Purchase Of Business: -759600000.00
SYNT.L cash_flow (annual, 2022-12-31) — Purchase Of PPE: -90800000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Raw Materials: 184800000.00
SYNT.L income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1918700000.00
SYNT.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 93900000.00
SYNT.L cash_flow (annual, 2022-12-31) — Repayment Of Debt: -207600000.00
SYNT.L income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 25700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Retained Earnings: 273500000.00
SYNT.L cash_flow (annual, 2022-12-31) — Sale Of Business: 300000.00
SYNT.L income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 72400000.00
SYNT.L income_statement (annual, 2022-12-31) — Selling General And Administration: 161500000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Share Issued: 63444920.00
SYNT.L income_statement (annual, 2022-12-31) — Special Income Charges: -138200000.00
SYNT.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 700000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1017000000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: -48300000.00
SYNT.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -25221300.00
SYNT.L income_statement (annual, 2022-12-31) — Tax Provision: -14600000.00
SYNT.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
SYNT.L balance_sheet (annual, 2022-12-31) — Taxes Receivable: 34300000.00
SYNT.L cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -65600000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Total Assets: 3047600000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 2251100000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Total Debt: 1298100000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1031000000.00
SYNT.L income_statement (annual, 2022-12-31) — Total Expenses: 2209300000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2016600000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1883200000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1433900000.00
SYNT.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -13500000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Total Tax Payable: 33600000.00
SYNT.L income_statement (annual, 2022-12-31) — Total Unusual Items: -113100000.00
SYNT.L income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -113100000.00
SYNT.L balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 9966.00
SYNT.L balance_sheet (annual, 2022-12-31) — Working Capital: 581700000.00
SYNT.L income_statement (annual, 2022-12-31) — Write Off: 133700000.00
SYNT.L income_statement (annual, 2023-12-31) — +Operating Expense: 320300000.00
SYNT.L income_statement (annual, 2023-12-31) — +Total Revenue: 1940600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 272100000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Accounts Receivable: 147600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -585600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 926800000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -1100000.00
SYNT.L income_statement (annual, 2023-12-31) — Amortization: 49300000.00
SYNT.L cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 8800000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 1500000.00
SYNT.L income_statement (annual, 2023-12-31) — Basic Average Shares: 85382000.00
SYNT.L income_statement (annual, 2023-12-31) — Basic EPS: -1.20
SYNT.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 209200000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 51400000.00
SYNT.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -84000000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 55300000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Capital Stock: 1600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 371300000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 371300000.00
SYNT.L cash_flow (annual, 2023-12-31) — Change In Inventory: 45700000.00
SYNT.L cash_flow (annual, 2023-12-31) — Change In Payable: -17800000.00
SYNT.L cash_flow (annual, 2023-12-31) — Change In Receivables: 52700000.00
SYNT.L cash_flow (annual, 2023-12-31) — Change In Working Capital: 80600000.00
SYNT.L cash_flow (annual, 2023-12-31) — Changes In Cash: 166800000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Common Stock: 1600000.00
SYNT.L cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: 0.00
SYNT.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1148600000.00
SYNT.L cash_flow (annual, 2023-12-31) — Common Stock Issuance: 265100000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Construction In Progress: 36700000.00
SYNT.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 1663600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Current Assets: 950900000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 13800000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Current Debt: 700000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 14500000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 488100000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Current Provisions: 11900000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 16500000.00
SYNT.L cash_flow (annual, 2023-12-31) — Depreciation: 96500000.00
SYNT.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 105300000.00
SYNT.L income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 153700000.00
SYNT.L income_statement (annual, 2023-12-31) — Depreciation Income Statement: -49300000.00
SYNT.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 85633000.00
SYNT.L income_statement (annual, 2023-12-31) — Diluted EPS: -1.20
SYNT.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -67000000.00
SYNT.L cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 1900000.00
SYNT.L income_statement (annual, 2023-12-31) — EBIT: -35800000.00
SYNT.L income_statement (annual, 2023-12-31) — EBITDA: 69500000.00
SYNT.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -5400000.00
SYNT.L cash_flow (annual, 2023-12-31) — End Cash Position: 370600000.00
SYNT.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: -90900000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Finished Goods: 180700000.00
SYNT.L cash_flow (annual, 2023-12-31) — Free Cash Flow: 66000000.00
SYNT.L cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 12100000.00
SYNT.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 92100000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Goodwill: 465700000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 989300000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 148700000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Gross PPE: 1291300000.00
SYNT.L income_statement (annual, 2023-12-31) — Gross Profit: 307300000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 12200000.00
SYNT.L income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 5600000.00
SYNT.L income_statement (annual, 2023-12-31) — Interest Expense: 75100000.00
SYNT.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 75100000.00
SYNT.L income_statement (annual, 2023-12-31) — Interest Income: 10200000.00
SYNT.L income_statement (annual, 2023-12-31) — Interest Income Non Operating: 10200000.00
SYNT.L cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -64500000.00
SYNT.L cash_flow (annual, 2023-12-31) — Interest Received Cfo: 10200000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Inventory: 344100000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Invested Capital: 2019600000.00
SYNT.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: 107700000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 7500000.00
SYNT.L cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 265100000.00
SYNT.L cash_flow (annual, 2023-12-31) — Issuance Of Debt: 548400000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Land And Improvements: 203200000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 41500000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Long Term Debt: 870300000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 911800000.00
SYNT.L cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 548400000.00
SYNT.L cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -892000000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 7500000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Long Term Provisions: 29600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1000000000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Minority Interest: 13400000.00
SYNT.L income_statement (annual, 2023-12-31) — Minority Interests: -200000.00
SYNT.L cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 189800000.00
SYNT.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 265100000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Net Debt: 499700000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Income: -67000000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -67000000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -104600000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 37800000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -67000000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -104800000.00
SYNT.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 17700000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -66800000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Interest Income: -64900000.00
SYNT.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -343600000.00
SYNT.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -343600000.00
SYNT.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -64900000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Net PPE: 705700000.00
SYNT.L cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -84000000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 159300000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 200000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 36800000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 33800000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 81200000.00
SYNT.L income_statement (annual, 2023-12-31) — Normalized EBITDA: 69500000.00
SYNT.L income_statement (annual, 2023-12-31) — Normalized Income: -104800000.00
SYNT.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: 150000000.00
SYNT.L income_statement (annual, 2023-12-31) — Operating Income: -39500000.00
SYNT.L income_statement (annual, 2023-12-31) — Operating Revenue: 1940600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 163566913.00
SYNT.L balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 523600000.00
SYNT.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: 16100000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Other Payable: 68100000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Other Receivables: 59800000.00
SYNT.L income_statement (annual, 2023-12-31) — Other Special Charges: 6200000.00
SYNT.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
SYNT.L balance_sheet (annual, 2023-12-31) — Payables: 368200000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 5600000.00
SYNT.L income_statement (annual, 2023-12-31) — Pretax Income: -110900000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Properties: 0.00
SYNT.L cash_flow (annual, 2023-12-31) — Purchase Of Business: -18400000.00
SYNT.L cash_flow (annual, 2023-12-31) — Purchase Of PPE: -84000000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Raw Materials: 163400000.00
SYNT.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1663600000.00
SYNT.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 105300000.00
SYNT.L cash_flow (annual, 2023-12-31) — Repayment Of Debt: -892000000.00
SYNT.L income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 16700000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Retained Earnings: 209800000.00
SYNT.L cash_flow (annual, 2023-12-31) — Sale Of Business: 208200000.00
SYNT.L cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
SYNT.L income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 74500000.00
SYNT.L income_statement (annual, 2023-12-31) — Selling General And Administration: 166600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Share Issued: 163567621.00
SYNT.L income_statement (annual, 2023-12-31) — Special Income Charges: -28500000.00
SYNT.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1800000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1148600000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: 159300000.00
SYNT.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
SYNT.L income_statement (annual, 2023-12-31) — Tax Provision: 13100000.00
SYNT.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.11
SYNT.L balance_sheet (annual, 2023-12-31) — Taxes Receivable: 8800000.00
SYNT.L cash_flow (annual, 2023-12-31) — Taxes Refund Paid: 9300000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Total Assets: 2706700000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 2018900000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Total Debt: 926300000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1162000000.00
SYNT.L income_statement (annual, 2023-12-31) — Total Expenses: 1983900000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1544700000.00
SYNT.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1755800000.00